Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any classic complement early component deficiency in which the cause of the disease is a mutation in the C8B gene.
Features include: Meningitis, Decreased circulating complement C8 concentration, and Recurrent Neisserial infections.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 1 | Meningitis |
Blood and immune system |
C8B encodes complement C8 beta chain (591 aa). Component of the membrane attack complex (MAC), a multiprotein complex activated by the complement cascade, which inserts into a target cell membrane and forms a pore, leading to target cell membrane rupture and cell lysis. Highest expression in Liver (295.3 TPM) and Lung (1.4 TPM).
Type II complement component 8 deficiency is associated with mutations in the C8B gene on chromosome 1.
C8B is classified as a druggable target (Druggable Genome category) with score 0.6.
Genetic testing for C8B is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for type II complement component 8 deficiency has been reported in the published literature.
No clinical trials have been registered for type II complement component 8 deficiency.
3 publications have been identified in PubMed for type II complement component 8 deficiency. Research spans Diagnostic / Biomarker (33%), Case Report / Case Series (33%), and Basic Science / Preclinical (33%).
Barbetti R (2026). [PMID: 42181774](https://pubmed.ncbi.nlm.nih.gov/42181774/). *Mol Genet Metab Rep*. [Case Report / Case Series]
Nayagam SM (2025). [PMID: 41372752](https://pubmed.ncbi.nlm.nih.gov/41372752/). *Clinical proteomics*. [Basic Science / Preclinical]
Lin X (2025). [PMID: 40599774](https://pubmed.ncbi.nlm.nih.gov/40599774/). *Frontiers in immunology*. [Diagnostic / Biomarker]
Data assembled from 5 of 12 sources · Last updated Sep 18, 2026, 12:50 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
1
Recurrent Neisserial infections |